Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q414762> ?p ?o }
Showing triples 1 to 70 of
70
with 100 triples per page.
- Q414762 subject Q13277549.
- Q414762 subject Q7029794.
- Q414762 subject Q7071513.
- Q414762 subject Q7335338.
- Q414762 subject Q7482068.
- Q414762 abstract "Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Etravirine is marketed by Tibotec, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for patients with established resistance to other drugs, making it the 30th anti-HIV drug approved in the United States and the first to be approved in 2008. It was also approved for use in Canada on April 1, 2008.Etravirine is licensed in the United States, Canada, Israel, Russia, Australia and the European Union, and is under regulatory review in Switzerland.".
- Q414762 atcPrefix "J05".
- Q414762 atcSuffix "AG04".
- Q414762 casNumber "269055-15-4".
- Q414762 drugbank "DB06414".
- Q414762 fdaUniiCode "0C50HW4FO1".
- Q414762 iupacName "4-[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile".
- Q414762 pubchem "193962".
- Q414762 thumbnail Etravirine_structure.svg?width=300.
- Q414762 wikiPageExternalLink etravirine_1618.shtml.
- Q414762 wikiPageExternalLink intelence.
- Q414762 wikiPageWikiLink Q1053948.
- Q414762 wikiPageWikiLink Q1128023.
- Q414762 wikiPageWikiLink Q127900.
- Q414762 wikiPageWikiLink Q13277549.
- Q414762 wikiPageWikiLink Q1363732.
- Q414762 wikiPageWikiLink Q14864419.
- Q414762 wikiPageWikiLink Q14916181.
- Q414762 wikiPageWikiLink Q14916187.
- Q414762 wikiPageWikiLink Q15787.
- Q414762 wikiPageWikiLink Q159.
- Q414762 wikiPageWikiLink Q16.
- Q414762 wikiPageWikiLink Q174211.
- Q414762 wikiPageWikiLink Q181381.
- Q414762 wikiPageWikiLink Q1878682.
- Q414762 wikiPageWikiLink Q204711.
- Q414762 wikiPageWikiLink Q219223.
- Q414762 wikiPageWikiLink Q263713.
- Q414762 wikiPageWikiLink Q28774.
- Q414762 wikiPageWikiLink Q30.
- Q414762 wikiPageWikiLink Q333718.
- Q414762 wikiPageWikiLink Q39.
- Q414762 wikiPageWikiLink Q421547.
- Q414762 wikiPageWikiLink Q421559.
- Q414762 wikiPageWikiLink Q422645.
- Q414762 wikiPageWikiLink Q458.
- Q414762 wikiPageWikiLink Q5272049.
- Q414762 wikiPageWikiLink Q5572341.
- Q414762 wikiPageWikiLink Q5958765.
- Q414762 wikiPageWikiLink Q658255.
- Q414762 wikiPageWikiLink Q7029794.
- Q414762 wikiPageWikiLink Q7071513.
- Q414762 wikiPageWikiLink Q7335338.
- Q414762 wikiPageWikiLink Q735188.
- Q414762 wikiPageWikiLink Q7482068.
- Q414762 wikiPageWikiLink Q801.
- Q414762 wikiPageWikiLink Q8386.
- Q414762 wikiPageWikiLink Q9368.
- Q414762 wikiPageWikiLink Q970208.
- Q414762 wikiPageWikiLink Q992172.
- Q414762 atcPrefix "J05".
- Q414762 atcSuffix "AG04".
- Q414762 casNumber "269055".
- Q414762 drugbank "DB06414".
- Q414762 iupacName "4".
- Q414762 pubchem "193962".
- Q414762 unii "0".
- Q414762 type ChemicalSubstance.
- Q414762 type Drug.
- Q414762 type ChemicalObject.
- Q414762 type Thing.
- Q414762 type Q8386.
- Q414762 comment "Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Etravirine is marketed by Tibotec, a subsidiary of Johnson & Johnson.".
- Q414762 label "Etravirine".
- Q414762 depiction Etravirine_structure.svg.